Public health officials are investigating the first human case of H5 bird flu detected in Los Angeles County after a person was exposed to infected livestock.
With Alhemo (concizumab-mtci) from Novo Nordisk A/S, a third hemophilia drug in the past eight months has been approved by the U.S. FDA. The once-daily injectable prophylaxis is to prevent or reduce ...
Panelists discuss how venous thromboembolism risk assessment and prophylaxis decisions in patients with non–small cell lung cancer require careful consideration of individual risk factors, patient ...
Concizumab is a tissue factor pathway inhibitor antagonist that enhances factor Xa production during the initiation phase of coagulation. This production improves thrombin generation and clot ...
Extracellular vesicles (EVs) have emerged as a transformative platform in biomedical research, especially in the domains of diagnosis, prophylaxis, and ...